Log In
Print
BCIQ
Print
Print this Print this
 

Xofigo (Radium-223) (BAY88-8223) (formerly Alpharadin)

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionRadiopharmaceutical based on the alpha particle emitter radium-223
Molecular Target Not available
Mechanism of ActionRadiation sensitizer
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today